However, CRISPR/Cas9-mediated knockout of TIM1 did not impair infection of either Huh-7.5 human hepatoma cells or Vero cells by naked HAV (Fig. 1F and 2D). This evidence concerns the gene HAVCR1 and hepatocellular carcinoma.